Latest News and Press Releases
Want to stay updated on the latest news?
-
Aeolus' AEOL 10150 Supresses Overexpression of 31 Hypoxia-Related Genes Caused by Radiation Exposure
MISSION VIEJO, CA--(Marketwire - Oct 17, 2012) - Aeolus Pharmaceuticals, Inc. (OTCQB: AOLS) AEOL 10150 improves tissue oxygenation and reduces hypoxia-associated...
-
MISSION VIEJO, CA--(Marketwire - Sep 6, 2012) - Aeolus Pharmaceuticals, Inc. (OTCQB: AOLS) (OTCBB: AOLS), a biotechnology company leveraging significant government funding to develop a platform of...
-
MISSION VIEJO, CA--(Marketwire - Aug 14, 2012) - Aeolus Pharmaceuticals, Inc. (OTCQB: AOLS) (OTCBB: AOLS) $1.4 million in revenue for third quarter 2012; $5.9...
-
MISSION VIEJO, CA--(Marketwire - Jul 30, 2012) - Aeolus Pharmaceuticals, Inc. (OTCQB: AOLS) (OTCBB: AOLS), a biotechnology company leveraging significant government funding to develop a platform of...
-
MISSION VIEJO, CA--(Marketwire - Jun 1, 2012) - Aeolus Pharmaceuticals, Inc. (OTCQB: AOLS) (OTCBB: AOLS), a biotechnology company leveraging significant government funding to develop a platform of...
-
MISSION VIEJO, CA--(Marketwire - May 14, 2012) - Aeolus Pharmaceuticals, Inc. (OTCQB: AOLS) (OTCBB: AOLS) $2.2 million in revenue for second quarter 2012; $4.4...
-
MISSION VIEJO, CA--(Marketwire - Apr 16, 2012) - Aeolus Pharmaceuticals, Inc. (OTCQB: AOLS) (OTCBB: AOLS), a biotechnology company leveraging significant government funding to develop a platform of...
-
MISSION VIEJO, CA--(Marketwire - Apr 9, 2012) - Aeolus Pharmaceuticals, Inc. (OTCQB: AOLS) (PINKSHEETS: AOLS) BARDA notice of intent to exercise options valued at...
-
MISSION VIEJO, CA--(Marketwire - Apr 5, 2012) - Aeolus Pharmaceuticals (OTCQB: AOLS) (PINKSHEETS: AOLS), a biotechnology company leveraging significant government funding to develop a platform of...
-
MISSION VIEJO, CA--(Marketwire - Mar 13, 2012) - Aeolus Pharmaceuticals, Inc. (OTCQB: AOLS) (PINKSHEETS: AOLS), a biotechnology company leveraging significant government funding to develop a...